Rabitec

RSS

Rabies vaccine (live, oral) for foxes and raccoon dogs

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Rabitec. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Rabitec.

This EPAR was last updated on 18/12/2017

Authorisation details

Product details
Name
Rabitec
Agency product number
EMEA/V/C/004387
Active substance
attenuated live rabies vaccine virus, strain SPBN GASGAS
International non-proprietary name (INN) or common name
Rabies vaccine (live, oral) for foxes and raccoon dogs
Species
  • Red foxes (Vulpes vulpes)
  • Raccoon dogs (Nyctereutes procyonoides)
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI07BD
Publication details
Marketing-authorisation holder
IDTBiologika GmbH
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
30/11/2017
Contact address
Am Pharmapark
06861 Dessau-Rosslau
Germany

Product information

01/12/2017 Rabitec - EMEA/V/C/004387 -

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • IMMUNOLOGICALS FOR CANIDAE
  • Live viral vaccines

Therapeutic indication

For the active immunisation of foxes and raccoon dogs against rabies to prevent infection and mortality.

Assessment history

How useful was this page?

Add your rating